Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
63,013,241
-
Total 13F shares
-
17,531,124
-
Share change
-
-404,582
-
Total reported value
-
$16,641,395
-
Price per share
-
$0.95
-
Number of holders
-
47
-
Value change
-
-$401,273
-
Number of buys
-
14
-
Number of sells
-
19
Institutional Holders of Cytosorbents Corp - Common Stock (CTSO) as of Q1 2024
As of 31 Mar 2024,
Cytosorbents Corp - Common Stock (CTSO) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,531,124 shares.
The largest 10 holders included
AVENIR CORP, Granahan Investment Management, LLC, Skylands Capital, LLC, VANGUARD GROUP INC, NEUBERGER BERMAN GROUP LLC, Sargent Investment Group, LLC, CM Management, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, and CIBC Private Wealth Group, LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.